Abstract
Despite continuously improving diagnostic facilities, respiratory chain disorders (RCDs) are easily overlooked or misdiagnosed. We thus studied phenotype variability and the diagnostic pootential of clinical and laboratory investigations in patients with RCD. We retrospectively evaluated clinical and laboratory investigations in 130 patients with RCD: 63 women and 67 men, aged 17–87 years, diagnosed between January 1992 and December 1999. mtDNA mutations were found in 20 patients; a respiratory chain defect but no mutation in 4; an abnormal lactate stress test but no mutation or biochemical defect in 66; and ragged-red fibres or reduced oxidative enzyme staining but no mutation, biochemical defect or abnormal lactate stress test in 40 patients. The most frequent initial manifestation of RCD were limb weakness, muscle pain and sensory disturbances. The most frequent clinical findings at diagnosis were muscle pain, fatiguability, limb weakness, reduced tendon reflexes and muscle wasting, irrespective of the diagnostic evidence. Mean age at onset, disease duration and time until diagnosis were 39, 14 and 13 years, respectively, without sex differences. The family history was positive in 29% of the patients. Hyperlipidaemia was found in 45%, hyper-CK-aemia in 42%, short stature in 33%, thyroid dysfunction in 17%, diabetes in 12%, and epilepsy in 8% of the patients. Laboratory investigations that prove useful to support the diagnosis of RCD are muscle biopsy, electromyography, lactate stress testing, echocardiography and mtDNA analysis. Systems most often involved in RCDs were the PNS, CNS, endocrine system and heart. The diagnosis of RCD requires awareness of the great phenotypic heterogeneity and an individualized, integral, multidisciplinary approach.
Similar content being viewed by others
REFERENCES
Andreu AL, Hanna MG, Reichmann H, et al (1999) Exercise intolerance due to mutations in the cytochrome b gene of mitochondrial DNA. N Engl J Med 341: 1037-1044.
Chinnery PF, Turnbull DM (1997) Clinical features, investigation, and management of patients with defects of mitochondrial DNA. J Neurol Neurosurg Psychiatry 63: 559-563.
Chinnery PF, Howell N, Lightowlers RN, Turnbull DM (1997) Molecular pathology of MELAS and MERRF. The relation between mutation and clinical phenotypes. Brain 120: 1713-1721.
DiMauro S (1999) Mitochondrial encephalomyopathies: back to mendelian genetics. Ann Neurol 45: 693-694.
DiLazzaro V, Restuccia D, Servidei S, et al. (1997) Functional involvement of central nervous system in mitochondrial disorders. Electroencephalogr Clin Neurophysiol 105: 171-180.
DiMauro S (1996) Mitochondrial myopathies: what next? J Inherit Metab Dis 19: 489-503.
Fadic R, Johns DR (1996) Clinical spectrum of mitochondrial diseases. Semin Neurol 16: 11-20.
Finsterer J (2001) Visually evoked potentials in respiratory chain disorders. Acta Neurol Scand 103 (in press).
Finsterer J, Fuglsang-Frederiksen A (1999) Macro-EMG in mitochondriopathy. Clin Electrophysiol 110: 1466-1470.
Finsterer J, Stöllberger C (1998) Hypertrabeculated left ventricle in mitochondriopathy. Heart 80: 632.
Finsterer J, Stöllberger C, Köcher K, Mamoli B (1997a) ECG abnormalities in myopathies, coronary heart disease and controls. Herz 22: 277-282.
Finsterer J, Stöllberger C, Keller H, Slany J, Mamoli B (1997b) Cardiac involvement in patients with myotonic dystrophy, Becker's muscular dystrophy and mitochondrial myopathy. Herz 22: 96-103.
Finsterer J, Stratil U, Bittner R, Sporn P (1998) Increased sensitivity to rocuronium and atracurium in mitochondrial myopathy. Can J Anaesth 45: 781-784.
Finsterer J, Eichberger H, Jarius C (2000a) Lactate stress testing in 54 patients with mitochondriopathy. Eur Arch Psychiatry Clin Neurosci 250: 36-39.
Finsterer J, Obermann I, Milvay E (2000b) Diagnostic yield of the lactate stress test in 160 patients with suspected respiratory chain disorder. Metab Brain Dis 15: 163-171.
Finsterer J, Bittner R, Bodingbauer M, Eichberger H, Stöllberger C, Blazek G (2000c) Complex mitochondriopathy associated with 4 mtDNA transitions. Eur Neurol 44: 37-41.
Franceschetti S, Antozzi C, Binelli S, Carrara F, Nardocci N, Zeviani M (1993) Progressive myoclonic epilepsies: an electroclinical, biochemical, morphological and molecular genetic study of 17 cases. Acta Neurol Scand 87: 219-223.
Fujimoto S, Mizuno K, Shibata H, et al (1999) Serial encephalographic findings in patients with MELAS. Pediatr Neurol 20: 43-48.
Goto Y-I (1995) Clinical features of MELAS and mitochondrial DNA mutations. Muscle Nerve (supplement 3) 18: S107-S112.
Jackson MJ, Schaefer JA, Johnson MA, Morris AAM, Turnbull DM, Bindoff LA (1995) Presentation and clinical investigation of mitochondrial respiratory chain disease. A study of 51 patients. Brain 118: 339-357.
Lee CP, Martens ME (1994) Mitochondrial respiration and energy metabolism in muscle. In Engel AG, Franzini-Armstrong C, eds. Myology. Basic and Clinical. New York: McGraw-Hill, 624-647.
Leonard JV, Schapira AHV (2000a) Mitochondrial respiratory chain disorders I: mitochondrial DNA defects. Lancet 355: 299-304.
Leonard JV, Schapira AHV (2000b) Mitochondrial respiratory chain disorders II: neurodegenerative disorders and nuclear gene defects. Lancet 355: 389-394.
Lindner A, Hofmann E, Naumann M, Becker G, Reichmann H (1997) Clinical, morphological, biochemical, and neuroradiological features of mitochondrial encephalomyopathies. Presentation of 19 cases. Mol Cell Biochem 174: 297-303.
Moraes CT (1996) Mitochondrial disorders. Curr Opin Neurol 9: 369-374.
Morgan-Hughes JA (1994) The mitochondrial myopathies. In Engel AG, Franzini-Armstrong C, eds. Myology. Basic and Clinical. New York: McGraw-Hill, 1610-1651.
Reichmann H, DiMauro S, (1998) Mitochondrial medicine. Akt Neurol 25: 351-360.
Schapira AHV, Cock HR (1999) Mitochondrial myopathies and encephalomyopathies. Eur J Clin Invest 29: 886-898.
Schapira AHV, DiMauro S (1994) Mitochondrial Disorders in Neurology. London: Butterworth Heinemann, 75-76.
Servidei S (2001) Mitochondrial encephalomyopathes: gene mutation. Neuromusc Disord 11: 121-130.
Smith SJ, Harding AE (1993) EEG and evoked potential findings in mitochondrial myopathies. J Neurol 240: 367-372.
Stöllberger C, Finsterer J, Blazek G. (2001) Isolated left ventricular abnormal trabeculation: follow-up and association with neuromuscular disorders. Can J Cardiol 17: 163-168.
Tulinius MH, Hagne I (1991) EEG findings in children and adolescents with mitochondrial encephalomyopathies: a study of 25 cases. Brain Dev 13: 167-173.
Van Goethem G, Martin J-J, Löfgren A (1997) Unusual presentation and clinical variability in Belgian pedigrees with progressive external ophthalmoplegia and multiple deletions of mitochondrial DNA. Eur J Neurol 4: 476-484.
Walker UA, Collins S, Byrne E (1996) Respiratory chain encephalomyopathies: a diagnostic classification. Eur Neurol 36: 260-267.
Zeviani M, Bertagniolio B, Uziel G (1996) Neurological presentations of mitochondrial diseases. J Inherit Metab Dis 19: 504-519.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Finsterer, J., Jarius, C., Eichberger, H. et al. Phenotype variability in 130 adult patients with respiratory chain disorders. J Inherit Metab Dis 24, 560–576 (2001). https://doi.org/10.1023/A:1012415810881
Issue Date:
DOI: https://doi.org/10.1023/A:1012415810881